ARGONAUT THERAPEUTICS

argonaut-therapeutics-logo

Argonaut Therapeutics is a precision therapeutics company that was established to develop epigenetically-acting drugs which target abnormal arginine methylation in cancer. The company was founded on pioneering research from the University of Oxford, UK. Argonaut strives to develop a new class of precision cancer medicines which target the enzymes responsible for abnormal arginine methylation in cancer.

#SimilarOrganizations #People #Financial #Website #More

ARGONAUT THERAPEUTICS

Social Links:

Industry:
Health Care Therapeutics

Founded:
2016-01-01

Address:
Oxford, Oxfordshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.argonauttherapeutics.co.uk

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
2.57 M USD

Technology used in webpage:
Euro British Server Location


Similar Organizations

stipe-therapeutics-logo

STipe Therapeutics

STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.

tivorsan-pharmaceuticals-logo

Tivorsan Pharmaceuticals

Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.


Current Advisors List

simon-kerry_image

Simon Kerry Non Executive Chairman @ Argonaut Therapeutics
Board_member
2017-01-01

Current Employees Featured

nick-la-thangue_image

Nick La Thangue
Nick La Thangue Chief Executive Officer @ Argonaut Therapeutics
Chief Executive Officer

Founder


nick-la-thangue_image

Nick La Thangue

Investors List

jw-pharmaceuticals_image

JW Pharmaceuticals

JW Pharmaceuticals investment in Corporate Round - Argonaut Therapeutics

oxford-sciences-innovation_image

Oxford Science Enterprises

Oxford Science Enterprises investment in Seed Round - Argonaut Therapeutics

Official Site Inspections

http://www.argonauttherapeutics.co.uk

  • Host name: 95.179.226.156.vultrusercontent.com
  • IP address: 95.179.226.156
  • Location: London United Kingdom
  • Latitude: 51.5128
  • Longitude: -0.0638
  • Timezone: Europe/London
  • Postal: E1

Loading ...

More informations about "Argonaut Therapeutics"

Argonaut Therapeutics - Crunchbase Company Profile & Funding

Argonaut Therapeutics is a precision therapeutics company that was established to develop epigenetically-acting drugs which target abnormal arginine methylation in cancer. The โ€ฆSee details»

Argonaut Therapeutics - VentureRadar

Argonaut Therapeutics is a precision therapeutics company that was established to develop epigenetically-acting drugs which target abnormal arginine methylation in cancer. The โ€ฆSee details»

Argonaut Therapeutics: Contact Details and Business Profile

Argonaut Therapeutics is a Biotechnology Research, Biotechnology, and Health Care company_reader located in UK with $6 million in revenue and 5 employees. Find top โ€ฆSee details»

Argonaut Therapeutics - PitchBook

Argonaut Therapeutics General Information Description. Developer of novel epigenetic therapies designed to offer treatment for arginine methylation in โ€ฆSee details»

Argonaut Therapeutics - Overview, News & Similar companies

Argonaut Therapeutics contact info: Phone number: +44 1865784874 Website: www.argonauttherapeutics.co.uk What does Argonaut Therapeutics do? Argonaut โ€ฆSee details»

Argonaut Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...

Explore Argonaut Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Endocrinology and Metabolic Disease ...See details»

ARGONAUT THERAPEUTICS LIMITED - Companies House

Accounts. Next accounts made up to 31 December 2024 due by 30 September 2025 Last accounts made up to 30 June 2023See details»

Argonaut Therapeutics - EU-Startups

UK. Business Description. Argonaut Therapeutics is a spin-out from Oxford Universityโ€™s Medical Sciences Division focusing on new cancer treatments. The technology is based on original discoveries made in Oxford that characterised โ€ฆSee details»

Argonaut Therapeutics Ltd.:Company Profile & Technical Research ...

Argonaut Therapeutics Ltd. is a company that provides Pharmacy and Therapeutics, Arginine, Methylation and more. Argonaut Therapeutics Ltd. is headquartered in United Kingdom .See details»

Argonaut Therapeutics Limited - Company Profile - Endole

Argonaut Therapeutics Limited is an active company incorporated on 8 February 2016 with the registered office located in Oxford, Oxfordshire. Argonaut Therapeutics Limited has been โ€ฆSee details»

Celleron Therapeutics and Argonaut Therapeutics Announce

Jan 5, 2023 For more information see https://argonauttherapeutics.co.ukAbout Oxford Science Enterprises. Oxford Science Enterprises (OSE) is an independent, billion-pound investment โ€ฆSee details»

Argonaut Therapeutics - Company Profile - Tracxn

Argonaut Therapeutics - Developing novel inhibitors of protein arginine methyl-transferase (PRMT) to treat cancer. Raised a total funding of $2.6M over 2 rounds from 3 investors. โ€ฆSee details»

Oxford spinout to develop cancer therapies which reprogram โ€ฆ

Argonaut, seed funding, investment, Oxford Sciences Innovation, University of Oxford, personalised medicine, apoptosis, tumour cell deathSee details»

ARGONAUT THERAPEUTICS LIMITED - Companies House

ARGONAUT THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, โ€ฆSee details»

Celleron Therapeutics and Argonaut Therapeutics Announce โ€ฆ

Jan 5, 2023 For more information see https://argonauttherapeutics.co.uk. About Oxford Science Enterprises. Oxford Science Enterprises (OSE) is an independent, billion-pound investment โ€ฆSee details»

Argonaut Therapeutics - VentureRadar

Biosceptre United Kingdom Privately Held Biosceptre is a UK headquartered biotech developing next-generation cancer therapeutics utilising its proprietary target, nfP2X7.Biosceptre has โ€ฆSee details»

Argonaut Therapeutics Announces Appointment of New Board โ€ฆ

Oxford, UK, 21 January 2021 - Argonaut Therapeutics, a leading developer of novel cancer agents, announced the appointment of Dr Chan Hee Park to its Board of Directors, โ€ฆSee details»

Argonaut Therapeutics Announces Successful Completion of โ€ฆ

Oxford, UK, March 2019 - Argonaut Therapeutics, a leading developer of novel cancer therapies, announced that it has raised new capital in its latest financing round. The financing included โ€ฆSee details»

Company Information - RocketReach

The most common Argonaut Therapeutics email format is [first].[last] (ex. [email protected]), which is being used by 75.0% of Argonaut โ€ฆSee details»

Celleron Therapeutics and Argonaut Therapeutics Announce โ€ฆ

For more information see https://argonauttherapeutics.co.uk About Oxford Science Enterprises . Page 3 of 3 Oxford Science Enterprises (OSE) is an independent, billion-pound investment โ€ฆSee details»

linkstock.net © 2022. All rights reserved